ATE82772T1 - Transformation von aspergillus niger und dabei zu verwendende plasmide. - Google Patents

Transformation von aspergillus niger und dabei zu verwendende plasmide.

Info

Publication number
ATE82772T1
ATE82772T1 AT85308827T AT85308827T ATE82772T1 AT E82772 T1 ATE82772 T1 AT E82772T1 AT 85308827 T AT85308827 T AT 85308827T AT 85308827 T AT85308827 T AT 85308827T AT E82772 T1 ATE82772 T1 AT E82772T1
Authority
AT
Austria
Prior art keywords
niger
transformation
dna
aspergillus niger
plasmids
Prior art date
Application number
AT85308827T
Other languages
English (en)
Inventor
Francis Paul Buxton
David Ivor Gwynne
Roger Wayne Davies
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24723387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE82772(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Application granted granted Critical
Publication of ATE82772T1 publication Critical patent/ATE82772T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/917Aspergillus niger

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Vehicle Body Suspensions (AREA)
  • Control Of Eletrric Generators (AREA)
AT85308827T 1984-12-05 1985-12-04 Transformation von aspergillus niger und dabei zu verwendende plasmide. ATE82772T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/678,578 US4885249A (en) 1984-12-05 1984-12-05 Aspergillus niger transformation system
EP85308827A EP0184438B1 (de) 1984-12-05 1985-12-04 Transformation von Aspergillus niger und dabei zu verwendende Plasmide

Publications (1)

Publication Number Publication Date
ATE82772T1 true ATE82772T1 (de) 1992-12-15

Family

ID=24723387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85308827T ATE82772T1 (de) 1984-12-05 1985-12-04 Transformation von aspergillus niger und dabei zu verwendende plasmide.

Country Status (8)

Country Link
US (1) US4885249A (de)
EP (1) EP0184438B1 (de)
JP (1) JPS61162168A (de)
AT (1) ATE82772T1 (de)
AU (1) AU590733B2 (de)
CA (1) CA1341342C (de)
DE (1) DE3586858T2 (de)
DK (1) DK175213B1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723292A (en) * 1984-05-25 1998-03-03 Zymogenetics, Inc. Stable DNA constructs
US6004785A (en) 1985-08-29 1999-12-21 Genencor International Inc. Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
US5364770A (en) * 1985-08-29 1994-11-15 Genencor International Inc. Heterologous polypeptides expressed in aspergillus
US5536661A (en) * 1987-03-10 1996-07-16 Novo Nordisk A/S Process for the production of protein products in aspergillus
US5766912A (en) 1986-03-17 1998-06-16 Novo Nordisk A/S Humicola lipase produced in aspergillus
FI872102L (fi) * 1986-06-06 1987-12-07 Panlabs Inc Expressionssystem hos filamentala fungi.
GB8702475D0 (en) 1987-02-04 1987-03-11 Ciba Geigy Ag Expression system
US5447862A (en) * 1987-02-04 1995-09-05 Ciba-Geigy Corporation Pectin lyase genes of aspergillus niger
EP0305216B1 (de) * 1987-08-28 1995-08-02 Novo Nordisk A/S Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen
JP2748347B2 (ja) * 1989-03-09 1998-05-06 キッコーマン 株式会社 アスペルギルス・ソーヤ形質転換体
IE68457B1 (en) * 1990-01-29 1996-06-26 Ciba Geigy Ag Novel fungal expression system
US5290474A (en) * 1990-10-05 1994-03-01 Genencor International, Inc. Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
CA2093422C (en) * 1990-10-05 2001-04-03 Genencor International, Inc. DETERGENT COMPOSITIONS CONTAINING LOW CBH I CONTENT CELLULASE COMPOSITIONS
CA2091236C (en) * 1992-03-09 2000-06-20 Akira Tsukamoto Ornithine carbamoyl transferase gene and utilization of the dna
DK36592D0 (da) * 1992-03-20 1992-03-20 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
US5846802A (en) * 1992-04-15 1998-12-08 Buxton; Frank Fungal Protease
DK47493D0 (da) * 1993-04-27 1993-04-27 Novo Nordisk As Fremgangsmaade til fremstilling af ost
US5674728A (en) * 1993-11-03 1997-10-07 Novartis Corporation Aspergillus niger vacuolar aspartyl protease
US6268140B1 (en) 1994-02-03 2001-07-31 Neugenesis Combinatorial metabolic libraries
US5643745A (en) * 1994-02-03 1997-07-01 University Of Hawaii Heterologous dimeric proteins produced in heterokaryons
US5683899A (en) 1994-02-03 1997-11-04 University Of Hawaii Methods and compositions for combinatorial-based discovery of new multimeric molecules
ATE256191T1 (de) * 1994-06-17 2003-12-15 Novozymes As Ein pilz, in dem das area-gen verändert ist, und ein area-gen aus aspergillus oryzae
WO1996000786A1 (en) * 1994-06-29 1996-01-11 Genencor International, Inc. INCREASED PRODUCTION OF β-GALACTOSIDASE IN ASPERGILLUS ORYZAE
AU1092897A (en) * 1995-12-15 1997-07-14 Novo Nordisk A/S A funguns wherein the area, pepc and/or pepe genes have been inactivated
US5776730A (en) * 1995-12-15 1998-07-07 University Of Hawaii Neurospora hosts for the production of recombinant proteins, and methods for producing same
US7883872B2 (en) * 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
US5811381A (en) * 1996-10-10 1998-09-22 Mark A. Emalfarb Cellulase compositions and methods of use
GB9907461D0 (en) 1999-03-31 1999-05-26 King S College London Neurite regeneration
KR100618495B1 (ko) * 1998-10-06 2006-08-31 마크 아론 에말파브 섬유상의 진균성 숙주 영역에서의 형질전환 시스템:크리소스포륨속에서
US8372620B2 (en) 1998-12-23 2013-02-12 Dupont Nutrition Biosciences Aps Bacterial xylanases
WO2001012780A1 (en) * 1999-08-13 2001-02-22 Suntory Limited Microorganism secreting out lipid and process for producing the lipid and lipid balls having the lipid encapsulating therein by using the microorganism
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
CA2706364A1 (en) 2000-12-07 2002-06-13 Dsm Ip Assets B.V. Method for the prevention or reduction of haze in beverages
ATE475324T1 (de) 2000-12-07 2010-08-15 Dsm Ip Assets Bv Mit carboxy-terminal prolin peptide angereicherte proteinhydrolysate
CZ20032454A3 (en) 2001-03-22 2004-03-17 Novo Nordisk Health Care Ag Coagulation factor vii derivative
GB0116453D0 (en) 2001-07-05 2001-08-29 Imp College Innovations Ltd Method
JP4088097B2 (ja) * 2002-04-26 2008-05-21 サントリー株式会社 高度不飽和脂肪酸含有脂質の製造方法
US8257760B2 (en) 2002-06-07 2012-09-04 Dsm Ip Assets B.V. Method for the prevention or reduction of haze in beverages
AU2003258395A1 (en) * 2002-08-30 2004-03-19 Puratos Naamloze Vennootschap Myrothecium sp. transformation and expression system
ES2383366T3 (es) 2003-06-25 2012-06-20 Novozymes A/S Enzimas para el tratamiento de almidón
WO2005003311A2 (en) 2003-06-25 2005-01-13 Novozymes A/S Enzymes for starch processing
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
WO2005042243A1 (en) * 2003-10-31 2005-05-12 Pirelli Pneumatici S.P.A. An expandable bladder for tyre-curing apparatuses, a manufacturing method thereof, and a process for manufacturing tyres for vehicle wheels
US20050181509A1 (en) * 2004-02-12 2005-08-18 The Penn State Research Foundation Dual selection based, targeted gene disruption method for fungi and fungus-like organisms
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
ZA200702695B (en) * 2004-10-15 2009-12-30 Neugenesis Corp Methods and compositions for combinatorial-based production of multivalent recombinant antigens
EP1831384B1 (de) 2004-12-22 2015-08-12 Novozymes A/S Polypeptide mit glucoamylase-aktivität und diese codierende polynukleotide
CN1298837C (zh) * 2005-07-28 2007-02-07 秘鸣 一种黑曲霉真菌及其在普洱茶生产中的应用
JP5690047B2 (ja) 2005-09-14 2015-03-25 ノボ ノルディスク ヘルス ケア アーゲー ヒト凝固第vii因子ポリペプチド
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
EP1941025B1 (de) 2005-10-17 2011-06-29 Novozymes A/S Verwendung von pilzmutanten zur expression von antikörpern
CA2630445C (en) 2005-11-28 2016-11-15 Dsm Ip Assets B.V. Enzyme preparations yielding a clean taste
GB0600406D0 (en) 2006-01-10 2006-02-15 Univ Bath Crystal
EP2505651A3 (de) 2006-12-10 2013-01-09 Dyadic International, Inc. Pilzisolate mit reduzierter Proteaseaktivität
US9862956B2 (en) 2006-12-10 2018-01-09 Danisco Us Inc. Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
NZ598285A (en) 2007-01-30 2013-10-25 Syngenta Participations Ag Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
CA2676686C (en) 2007-02-20 2015-12-15 Dsm Ip Assets B.V. Novel sialidase
EP2126060B1 (de) 2007-03-22 2016-10-05 DSM IP Assets B.V. Neue lysyl-oxidasen
US8551751B2 (en) * 2007-09-07 2013-10-08 Dyadic International, Inc. BX11 enzymes having xylosidase activity
WO2009019314A1 (en) 2007-08-08 2009-02-12 Novozymes A/S Transferrin variants and conjugates
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
JP2012516878A (ja) 2009-02-06 2012-07-26 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 精製プロセス
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
US20120282285A1 (en) 2009-07-17 2012-11-08 Rigshospitalet Masp isoforms as inhibitors of complement activation
CA2771999A1 (en) 2009-08-24 2011-03-10 Amunix Operating Inc. Coagulation factor vii compositions and methods of making and using same
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
WO2011101339A2 (en) 2010-02-18 2011-08-25 Dsm Ip Assets B.V. Fermentation broth and filtration filter cake and uses thereof
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
WO2012007445A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Mutarotase in crystallization
WO2012007446A1 (en) 2010-07-13 2012-01-19 Dsm Ip Assets B.V. Use of a mutarotase in the production of dried powders
US9096871B2 (en) 2010-10-06 2015-08-04 Bp Corporation North America Inc. Variant CBH I polypeptides with reduced product inhibition
JP6206972B2 (ja) 2011-09-12 2017-10-04 アムニクス オペレーティング インコーポレイテッド グルカゴン様ペプチド−2組成物およびその作製法および使用法
SG10201606195UA (en) 2012-02-09 2016-09-29 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
JP6256882B2 (ja) 2012-02-15 2018-01-10 アムニクス オペレーティング インコーポレイテッド 第viii因子組成物、ならびに組成物の作製方法および用途
EP2822577B1 (de) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Rekombinante faktor-viii-proteine
EP2906693A1 (de) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Gerinnungsfaktor-vii-polypeptide
TW202003554A (zh) 2013-08-14 2020-01-16 美商百歐維拉提夫治療公司 因子viii-xten融合物及其用途
EA201890423A1 (ru) 2015-08-03 2018-07-31 Биовератив Терапьютикс Инк. Слитые белки фактора ix, способы их получения и применения
MX2019006444A (es) 2016-12-02 2019-10-30 Bioverativ Therapeutics Inc Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
PL3793588T3 (pl) 2018-05-18 2025-09-01 Bioverativ Therapeutics Inc. Sposoby leczenia hemofilii a
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
EP4023757A1 (de) 2020-12-29 2022-07-06 The Protein Brewery B.V. Verfahren zur erzeugung von selektionsmarkerfreien transformanten von heterokaryotischen organismen
CN114958899A (zh) * 2022-05-30 2022-08-30 福州大学 一种能在黑曲霉细胞内自主复制的复制子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486533A (en) * 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
EP0191221A1 (de) * 1984-10-24 1986-08-20 The Regents Of The University Of California Vektoren zur Transformation von Ascomyceten
US4735901A (en) * 1985-01-14 1988-04-05 E. R. Squibb & Sons, Inc. Transformation of Candida albicans
DE3650202T3 (de) * 1985-08-29 2004-06-03 Genencor International, Inc., South San Francisco Expression von heterologen Polypeptiden in filamentösen Pilzen, Verfahren zu deren Herstellung und Vektoren zu deren Herstellung.
FI864473L (fi) * 1985-11-20 1987-05-21 Panlabs Inc Sammansatta yttryckskassetter foer fungaltransformering.
US4935349A (en) * 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus

Also Published As

Publication number Publication date
DE3586858D1 (de) 1993-01-07
DE3586858T2 (de) 1993-05-19
EP0184438B1 (de) 1992-11-25
CA1341342C (en) 2002-02-26
AU5078085A (en) 1986-06-12
EP0184438A3 (en) 1988-01-13
DK562685A (da) 1986-06-06
EP0184438A2 (de) 1986-06-11
AU590733B2 (en) 1989-11-16
JPS61162168A (ja) 1986-07-22
DK562685D0 (da) 1985-12-04
DK175213B1 (da) 2004-07-12
US4885249A (en) 1989-12-05

Similar Documents

Publication Publication Date Title
ATE82772T1 (de) Transformation von aspergillus niger und dabei zu verwendende plasmide.
EP0249676A3 (de) Verfahren zur Genexpression in Pflanzen
IT8023051A0 (it) Particelle sferiche di carbone attivato adatte all'impiego in composizioni farmaceutiche controle intossicazioni.
IL66217A0 (en) Preparation and use of plasmids with genes for the biosynthesis of l-proline
DE3578435D1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
YU34586A (en) Process for obtaining new peptides
ZA914714B (en) A cell having a certain function in a process,containing recombinant dna encoding at least one enzyme,recombinant dna,enzyme for which the recombinant dna encodes and uses thereof
NO175871C (no) Gjærhybridpromotor, gjærhybridvektor, Saccharomyces spec.-vert, samt fremgangsmåte for fremstilling av et polypeptid heterologt med gjær
AU682140B2 (en) Multidrug resistance gene
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
EP0079739A3 (de) Auf Albumin basierende Nukleotiden, ihre Replikation und Verwendung und Plasmide zur Verwendung darin
DE3381566D1 (de) Hepatitis-b-virus-gen enthaltendes rekombinantes plasmid, mit diesem rekombinanten plasmid transformierte hefe und herstellung von hepatitis-b-virus-oberflaechenantigen.
IE840258L (en) Expression of gene products.
DE2963374D1 (en) Recombinant dna, method for preparing it and production of foreign proteins by unicellular hosts containing it
JPS5658488A (en) Refined "sake" with low alcohol content
EP0183654A3 (de) Drehelektrode aus Kohle oder Graphit für Elektroöfen mit offenem oder verdecktem Lichtbogen
GB9003010D0 (en) Gene expression in yeast cells
GR3033685T3 (en) Mutant interleukin 6 with improved biological activity over wild interleukin 6.
EP0240224A3 (de) Alpha-Interferon-Analogon
WO1992011370A3 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
ES8703932A1 (es) Un procedimiento para preparar una molecula de adn recombinante.
ATE64153T1 (de) Plasmide zur erhoehten produktion von penicillin g-amidase.
EP0211662A3 (de) Nod-D zugehörende Gene von Rhizobium japonicum 191
EP0155594A3 (de) Klonierte Plasmide von Corynebacterium
JPS5234772A (en) Electrochemical element